Clinical trial

A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications

NCT02796079

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE1

Study timeline

Study start (unknown)2015-01-01Date precision: month

Registry last updated2017-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Peripheral Vascular Diseaseunresolved

Ischemiaunresolved

Diabetic Footunresolved

Interventions

mesenchymal stem cellsBIOLOGICAL

salineBIOLOGICAL

Sponsors & collaborators

Jie Shenlead sponsor

Nanfang Hospital, Southern Medical Universitycollaborator

Academy Military Medical Science, Chinacollaborator

The Fifth Affiliated Hospital of Southern Medical Universitycollaborator

Southern Medical University, Chinacollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02796079 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.